Showing results (1-10 of 142) with videos related to

Sort By:
Pageof 15
Journal for Immunotherapy of Cancer|July 10, 2019
Rescue therapy for patients with anti-PD-1-refractory Merkel cell carcinoma: a multicenter, retrospective case seriesJaclyn LoPiccolo, Megan D Schollenberger, Sumia Dakhil, et al.
Critical Reviews in Oncology/Hematology|July 24, 2007
PTEN hamartomatous tumor syndromes (PHTS): rare syndromes with great relevance to common cancers and targeted drug developmentJaclyn Lopiccolo, Marc S Ballas, Phillip A Dennis
Autophagy|November 15, 2007
Nelfinavir, a new anti-cancer drug with pleiotropic effects and many paths to autophagyJoell J Gills, Jaclyn Lopiccolo, Phillip A Dennis
Nature Reviews. Clinical Oncology|January 10, 2024
Lung cancer in patients who have never smoked - an emerging diseaseJaclyn LoPiccolo, Alexander Gusev, David C Christiani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 9, 2011
Ipilimumab: an anti-CTLA-4 antibody for metastatic melanomaEvan J Lipson, Charles G Drake
Oncology (Williston Park, N.Y.)|November 12, 2014
Identification and management of toxicities from immune checkpoint-blocking drugsBenjamin A Teply, Evan J Lipson
In Vivo (Athens, Greece)|January 6, 2021
Combining Nelfinavir With Chloroquine Inhibits In Vivo Growth of Human Lung Cancer Xenograft TumorsJaclyn Lopiccolo, Shigeru Kawabata, Joell J Gills, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|January 2, 2008
Targeting the PI3K/Akt/mTOR pathway: effective combinations and clinical considerationsJaclyn LoPiccolo, Gideon M Blumenthal, Wendy B Bernstein, et al.
Anti-Cancer Drugs|August 2, 2007
Targeting Akt in cancer therapyJaclyn LoPiccolo, Courtney A Granville, Joell J Gills, et al.
Pageof 15